Vest Financial LLC Grows Stake in Chemed Corporation $CHE

Key Points

• Vest Financial LLC increased its stake in Chemed Corporation by 68.7%, owning 7,319 shares valued at $3,564,000 as of the latest SEC filing.
• Chemed's recent earnings report revealed an EPS of $4.27, falling short of analysts' expectations of $6.02, with quarterly revenue of $618.80 million.
• The company announced a quarterly dividend increase from $0.50 to $0.60, with a payout ratio of 12.34% and an annualized dividend yield of 0.6%.

Vest Financial LLC boosted its position in shares of Chemed Corporation (NYSE:CHE - Free Report) by 68.7% during the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 7,319 shares of the company's stock after purchasing an additional 2,981 shares during the quarter. Vest Financial LLC owned about 0.05% of Chemed worth $3,564,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors also recently bought and sold shares of the company. Renasant Bank increased its holdings in shares of Chemed by 2.3% in the 1st quarter. Renasant Bank now owns 815 shares of the company's stock valued at $501,000 after acquiring an additional 18 shares during the period. Cim LLC increased its holdings in shares of Chemed by 1.0% in the 1st quarter. Cim LLC now owns 2,029 shares of the company's stock valued at $1,248,000 after acquiring an additional 21 shares during the period. First Horizon Advisors Inc. increased its holdings in shares of Chemed by 16.1% in the 1st quarter. First Horizon Advisors Inc. now owns 173 shares of the company's stock valued at $107,000 after acquiring an additional 24 shares during the period. Cynosure Group LLC increased its holdings in shares of Chemed by 4.3% in the 1st quarter. Cynosure Group LLC now owns 581 shares of the company's stock valued at $358,000 after acquiring an additional 24 shares during the period. Finally, Farther Finance Advisors LLC increased its holdings in shares of Chemed by 23.0% in the 1st quarter. Farther Finance Advisors LLC now owns 150 shares of the company's stock valued at $93,000 after acquiring an additional 28 shares during the period. 95.85% of the stock is currently owned by hedge funds and other institutional investors.

Chemed Stock Performance

Shares of CHE opened at $429.20 on Tuesday. The stock has a 50-day moving average of $448.56 and a two-hundred day moving average of $507.92. Chemed Corporation has a one year low of $408.42 and a one year high of $623.60. The stock has a market cap of $6.25 billion, a P/E ratio of 22.07, a P/E/G ratio of 2.50 and a beta of 0.43.

Chemed (NYSE:CHE - Get Free Report) last issued its quarterly earnings results on Tuesday, July 29th. The company reported $4.27 EPS for the quarter, missing analysts' consensus estimates of $6.02 by ($1.75). Chemed had a return on equity of 25.83% and a net margin of 11.56%.The firm had revenue of $618.80 million for the quarter, compared to analyst estimates of $650.60 million. During the same period in the prior year, the firm posted $5.47 EPS. The business's revenue was up 3.8% compared to the same quarter last year. Chemed has set its FY 2025 guidance at 22.000-22.300 EPS. Analysts predict that Chemed Corporation will post 21.43 EPS for the current fiscal year.

Chemed Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, August 29th. Stockholders of record on Monday, August 11th were issued a $0.60 dividend. This is a boost from Chemed's previous quarterly dividend of $0.50. The ex-dividend date of this dividend was Monday, August 11th. This represents a $2.40 annualized dividend and a dividend yield of 0.6%. Chemed's payout ratio is presently 12.34%.

Insider Buying and Selling

In other news, Director Patrick P. Grace sold 150 shares of the business's stock in a transaction dated Tuesday, September 9th. The stock was sold at an average price of $463.39, for a total value of $69,508.50. Following the completion of the transaction, the director owned 3,397 shares of the company's stock, valued at $1,574,135.83. The trade was a 4.23% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, Director George J. Walsh III purchased 200 shares of the business's stock in a transaction that occurred on Monday, August 4th. The stock was acquired at an average price of $417.10 per share, with a total value of $83,420.00. Following the purchase, the director owned 3,523 shares in the company, valued at $1,469,443.30. This represents a 6.02% increase in their ownership of the stock. The disclosure for this purchase can be found here. In the last quarter, insiders sold 13,162 shares of company stock worth $5,677,511. Corporate insiders own 3.29% of the company's stock.

Analyst Ratings Changes

A number of brokerages have recently issued reports on CHE. Oppenheimer cut their price target on Chemed from $650.00 to $580.00 and set an "outperform" rating on the stock in a report on Thursday, July 31st. Jefferies Financial Group upgraded Chemed from a "hold" rating to a "buy" rating and lifted their price target for the company from $490.00 to $550.00 in a report on Tuesday, September 2nd. Bank of America lowered their price objective on Chemed from $610.00 to $595.00 and set a "buy" rating for the company in a research report on Wednesday, September 10th. Weiss Ratings reissued a "hold (c-)" rating on shares of Chemed in a research report on Wednesday, October 8th. Finally, Royal Bank Of Canada lowered their price objective on Chemed from $640.00 to $589.00 and set an "outperform" rating for the company in a research report on Thursday, July 31st. Four investment analysts have rated the stock with a Buy rating and one has given a Hold rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and a consensus target price of $578.50.

Chemed Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.